Leadership

Senior Executive

Prof Chris Goodnow FAA FRS

Executive Director 

Prof Chris GoodnowChris Goodnow is an internationally renowned immunologist. He joined Garvan in 2015. Chris has had an extensive international research career. He has been a faculty member at Stanford University and the Australian National University, and has been closely involved in several biotechnology start-up companies. He is best known for integrating molecular genetics and genomics with immunology, for which he received numerous awards and election to the Australian Academy of Science, the UK Royal Society, and the US National Academy of Science.

Prof Peter Croucher

Deputy Director

prof peter croucher

Prof Peter Croucher joined Garvan in 2011. Prof Croucher is a bone biologist and cancer researcher, with a longstanding fascination for disorders of the skeleton, particularly osteoporosis and cancer-associated bone disease. He completed his postdoctoral training at the University of Cambridge and the University of Sheffield.

Before becoming Deputy Director of Garvan, Prof Croucher led Garvan’s Healthy Ageing Research Theme, a multidisciplinary group of over 150 researchers and clinician-scientists who study range of diseases related to ageing.

Nat McGregor

Chief Operating Officer

Nat McGregor - _MMP5411 RGB (650x650px).jpgNat McGregor joins Garvan as Chief Operating Officer in 2020. Nat has over 20 years’ experience in financial and organisational leadership including holding the position of University of Newcastle Chief Operating Officer since 2013. Nat holds a Bachelor of Commerce (University of Newcastle), is CPA qualified, an MBA from Deakin University and is an alumni of both INSEAD and Columbia University business schools. Nat was an alternate Independent Director and Member of the Audit and Risk Committee for the Hunter Medical Research Institute and played a role in establishing the new Central Coast Research Institute.

 

Contact for the Board, Company Secretary and Chief Operating Officer: 

Gabriella O'Neil – Manager, Office of the COO
g.oneil@garvan.org.au 
tel: +61 (0) 2 9295 8120 

Contact for the Executive Director and Deputy Director: 

Bernadett Symonds– Executive Assistant to the Executive Office
b.symonds@garvan.org.au
tel: +61 (0) 2 9295 8135 


Prof Susan Clark

Research Theme Leader: Genomics and Epigenetics

Susan ClarkProf Susan Clark FAA leads Garvan’s Genomics and Epigenetics Theme and is Head of the Epigenetics Research Laboratory. Prof Clark is a worldwide pioneer of epigenetics – the study of the additional layer of instructions on DNA that organises and regulates gene activity. Her research has helped revolutionise the field through new technologies that profile DNA changes in early development and cancer, and has laid the groundwork for using epigenetics to detect and monitor cancer progression. She is a Fellow of the Australian Academy of Science, recipient of The Clive and Vera Ramaciotti Foundation: Medal of Excellence and in 2019 she was awarded a NHMRC Senior Principal Research Fellowship and received the NSW Premiers Prize for Excellence in Medical Biological Sciences.

Prof Katherine Samaras

Research Theme Leader: Healthy Ageing Research

Katherine SamarasProf Katherine Samaras leads the Healthy Ageing Theme at Garvan. She is Head of the Clinical Obesity, Nutrition and Adipose Biology Laboratory and an senior staff specialist in the Department of Endocrinology at St Vincent’s Hospital.  Prof Samaras is also Founder and Director of the Australian Centre for Metabolic Health addressing the diseases of diabetes and obesity, their treatment and prevention. Her research focuses on how diabetes and obesity adversely affect health and how this can be improved.

Prof Stuart Tangye

Research Theme Leader: Immunity and Inflammation

Stuart TangyeProf Stuart Tangye leads Garvan’s Immunity and Inflammation Theme and is Head of the Immunology and Immunodeficiency Laboratory at Garvan. Prof Tangye has a passionate interest for human immunology, cell biology and immune deficiencies. He has published over 100 peer reviewed articles and invited reviews. In 2011, he received the Gottschalk Medal from the Australian Academy of Sciences for his outstanding research in the medical sciences.  

Prof Paul Timpson

Research Theme Leader: Cancer

Paul TimsponProf Paul Timpson is Garvan’s Cancer Theme Leader and Head of the Invasion and Metastasis Laboratory. Prof Timpson joined Garvan in 2003 to investigate the role of the actin-binding protein cortactin in growth factor receptor trafficking in breast cancer and head and neck cancer. His research aims to understand the molecular drivers of cancer progression and the environmental cues that cause resistance to current systemic therapy.

Dr Daniel MacArthur

Director of Centre for Population Genomics

Daniel MacArthurDr Daniel MacArthur is the Director of the Centre for Population Genomics, a collaboration between Garvan and the Murdoch Children’s Research Institute. He previously served as Co-Director of the Medical and Population Genetics Program at the Broad Institute of MIT and Harvard, and headed up a team jointly based at the Broad Institute, Massachusetts General Hospital, and Harvard Medical School.Dr McArthur also led the development of the Genome Aggregation Database (gnomAD), the largest and most widely-used data set of human exome and genome sequence data.  

Mara-Jean Tilley 

Director of Garvan Research Foundation

Mara-JeanMara-Jean Tilley is the Director of the Garvan Research Foundation, Garvan’s marketing and fundraising arm. Formerly the Director of Philanthropy, Bequests and Campaigns, Mara-Jean commenced working at Garvan in 2011. Prior to joining Garvan, Mara-Jean was the Foundation Executive at the Sydney Theatre Company where she held a variety of positions over more than 8 years with the organisation. Mara-Jean is a member of the Perpetual Foundation and Centenary Foundation Advisory Committee.

Cleo Rowley 

Director of People and Culture 

Cleo RowleyCleo Rowley is the Garvan’s Director of People and Culture. Cleo has an extensive background in human resource management and delivering people strategies to drive sustainable business results. She is focused on developing collaborative relationships across all levels of the organisation to achieve win-win outcomes. Cleo has extensive experience in health & medical research, retail, information services, call centre, professional services and print media.


Board of Directors

The Garvan Institute of Medical Research is an autonomous, non-profit research institute incorporated by Act of NSW Parliament. Read more about the history of the Garvan Institute.

The Garvan Institute Board determines policy and controls the Institute's affairs. The board meets quarterly and comprises 15 members (including the Executive Director), nominated by Garvan's stakeholders and appointed by the Governor of New South Wales.

John Schubert AO - Chair

John Schubert

Nominated by the Trustees of St Vincent's Hospital

Dr Schubert is Chairman of the Garvan Institute of Medical Research, Chairman of the Great Barrier Reef Foundation, and a director of the Garvan Research Foundation Board. He has held positions as Chairman of the Commonwealth Bank of Australia, non-executive director of BHP Billiton Limited, BHP Billiton Plc, and Qantas Airways Limited, Chief Executive Officer of Pioneer International Limited, Chairman of WorleyParsons Limited and G2 Therapies Ltd, Chairman and MD of Esso Australia Ltd, and non-executive director of Hanson Plc.

Annabelle Bennett AC SC

Annabelle Bennett

Nominated by the Trustees of St Vincent's Hospital

The Hon Dr Bennett was formerly a Judge of the Federal Court of Australia. She is presently Chancellor of Bond University, President of the Anti-Discrimination Board of NSW, Arbitrator with the Court of Arbitration for Sport, Chair of the Australian Nuclear Science and Technology Organisation (ANSTO) and Chair of Gardior Pty Ltd, the trustee of The Infrastructure Fund (TIF). Dr Bennett has extensive knowledge and experience in intellectual property arising from her position as a Judge, as a senior counsel specialising in Intellectual Property and as President of the Copyright Tribunal.

Annette Cunliffe RSC

Annette Cunliffe

Nominated by the Sisters of Charity

Sister Annette was the Sisters of Charity Congregational Leader. She has been President of the Conference of Leaders of Religious Institutes (NSW),  President of Catholic Religious Australia, Inaugural Chair of the Stewardship Board of Catholic Health Australia, and a senior lecturer at the Australian Catholic University. Until the end of 2018 she was one of two executive officers of the National Committee for Professional Standards of the Catholic Church in Australia.

Stephen Johns 

Stephen Johns

Nominated by the Garvan Research Foundation

Mr Johns is a non-executive director and the Chairman Elect of Goodman Group. He is a former chairman and non-executive director of Brambles Limited, Leighton Holdings Limited and Spark Infrastructure Group, and former executive and non-executive director of Westfield Group. He has a Bachelor of Economics degree from the University of Sydney and is a Fellow of the Institute of Chartered Accountants in Australia and the Institute of Company Directors.

Paul Kelly

Paul Kelly

Nominated by the Trustees of St Vincent's Hospital

Dr Kelly is a founding managing partner of OneVentures, a leading Australian venture capital firm, and serves as Chair of the Investment Committee of its Healthcare fund, and on the Risk Management Committee. An Australian physician, serial entrepreneur and experienced biotechnology and life sciences executive, he currently has over 35 years’ experience in clinical medicine and medical science, and 25 years’ experience in commercialising life science related technologies in Australia, Europe and North America.

Helen Nugent AO

Helen Nugent

Nominated by the NSW Minister for Health

Dr Nugent is the Chairman of the National Disability Insurance Agency and Ausgrid, a non-executive director of Insurance Australia Group Limited and TPG Telecom. She has been the Chairman of Veda Group, Australian Rail Track Corporation, Funds SA, Swiss Re (Australia) and Sydney Airport and a non-executive director of Macquarie Group, Origin Energy Limited, Mercantile Mutual and the State Bank of NSW, among others. She is an Officer of the Order of Australia and a recipient of the Australian Government Centenary Medal and was recently awarded the Order of Merit by the Australian Olympic Committee.

Patricia O'Rourke

patricia-orourke130.jpg

Nominated by the Sisters of Charity

Adjunct Professor O’Rourke is the CEO of St Vincent’s Health Australia’s Public Hospitals Division. She also serves on the board of the Aikenhead Centre for Medical Discovery. She is a graduate of the Australian Institute of Company Directors and a member of the Harvard Business Club of Australia.

 

Vlado Perkovic

Perkovic_Vlado_photo_sq.jpg

Nominated by UNSW Sydney

Professor Perkovic is the Dean of the Faculty of Medicine at UNSW Sydney. Prior to this, he was the Executive Director of The George Institute since 2011, President of the Association of Australian Medical Research Institutes and on the Board of the Australian Clinical Trials Alliance. He is Chair of the International Society of Nephrology Advancing Clinical Trials (ISN-ACT) group; and is a fellow of the Royal Australasian College of Physicians, and of the Australian Academy of Health and Medical Sciences.

 

Anthony Schembri AM

Anthony Schembri

Nominated by the Sisters of Charity

Associate Professor Schembri is the CEO of St Vincent’s Health Network Sydney, is an Adjunct Professor in Health Sciences at the Australian Catholic University, Adjunct Professor at the School of Medicine, University of Notre Dame and Associate Professor of the Faculty of Medicine at UNSW Sydney. He is a director on the boards of Central & Eastern Sydney Primary Health Network, the National Centre for Clinical Research for Emerging Drugs, and the St Vincent’s Curran Foundation, and is co-chair of Australian Catholic University/St Vincent’s Nursing Research Institute. He has held a range of volunteer appointments in youth services, human rights and anti-violence organisations.

Russell Scrimshaw

Russell Scrimshaw

Nominated by the Federal Minister for Health

Dr Scrimshaw is the Garvan Research Foundation Board Chair. He is currently Non-Executive Chairman of Tech Project Group P/L, Deputy Chairman of Ignition Advice P/L and the Executive Chairman of Torrus Capital P/L, the Australian Philanthropic Fund, the Scrimshaw Foundation and Scrimshaw Nominees P/L. Previously, he held executive positions at Fortescue Metals Group Ltd (FMG), Commonwealth Bank, Optus and IBM. He was also a non- executive Board Director for Commonwealth Properties Ltd, EDS Australia, Mobilesoft Ltd, Telecom New Zealand Australia P/L, and Athletics Australia.

Jillian Segal AO

Jillian Segal

Nominated by UNSW Sydney

Ms Segal is the former Deputy Chancellor UNSW Sydney. She is the chairman of AICC (NSW), General Sir John Monash Foundation and the Independent Parliamentary Expenses Authority (IPEA). She is President of the Executive Council of Australian Jewry (ECAJ), a Trustee of the Sydney Opera House, a director of the Grattan Institute and of Rabobank Australia Limited. She is a member of the International Board of the Weizmann Institute of Science and of the Council for the Order of Australia,. She has been a senior regulator, lawyer and a director of other listed and government organisations.

Ronald Trent 

Ronald Trent

Nominated by the NSW Minister for Health

Professor Trent is Head of the Department of Medical Genomics at the Royal Prince Alfred Hospital. He is Director for the Institute of Precision Medicine & Bioinformatics at the Sydney Local Health District, and Director of Sydney LHD Institute of Precision Medicine & Bioinformatics. He is President of the School Council for the Sydney Boys High School, and Secretary of the Sydney Girls High School Foundation. He is a fellow of the Royal Australasian College of Physicians, the Royal College of Pathologists of Australasia, and of the Australian Academy of Technology and Engineering.